On June 4, 2025, Morpheus Research published a report alleging the company is generating fake revenue through aggressive “mark-to-model” accounting tied to its life settlements portfolio. According to the report, Abacus books revenue by marking up policies using internal life expectancy estimates that understate how long insured individuals will live. Morpheus also cites undisclosed related-party transactions and policy markups of over 80% within days of purchase.
Following this news, shares of Abacus fell over 15% in intraday trading on the same day.
To receive more information, please fill out the form.
